Myelofibrosis - 57 Studies Found Active, not recruiting : Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis : Myelofibrosis : 2013-03-14 : Drug: A: Fludarabine + Busulphan Completed : Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis : Myelofibrosis : 2007-12-11 : Drug: arsenic trioxide Recruiting : A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis : Myelofibrosis : 2017-02-27 : Drug: Ruxolitinib Ruxolitinib Completed : Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients : Myelofibrosis : 2008-01-11 : Procedure: Allogeneic Stem Cell Transplantation Allogeneic Stem Cell Transplantation after dose-reduced Recruiting : Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg : Myelofibrosis : 2016-03-08 : Drug: Ruxolotinib Ruxolitinib Active, not recruiting : Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis : Myelofibrosis : 2012-12-24 : Drug: Peginterferon alfa-2a 50 mcg subcutaneous injection once per week Suspended : Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor : Primary Myelofibrosis : 2015-04-21 : Drug: Imetelstat 9.4 milligram/kilogram (mg/kg) Terminated : A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial) : Primary Myelofibrosis : 2014-03-06 : Drug: Ruxolitinib Starting dose was based on reason for previous discontinuation of ruxolitinib (i.e. lo Completed : Thalidomide in Treating Patients With Myelofibrosis : Primary Myelofibrosis : 2001-05-06 : Drug: thalidomide Given PO Withdrawn : A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis : Primary Myelofibrosis : 2015-10-21 : Biological: Pacritinib QD (Once a day) <<< Previous | Next >>>